| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Envoy Medical, Inc.: Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology | 170 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - May 20, 2026) - Envoy Medical Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance... ► Artikel lesen | |
| Mo | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.05. | Envoy Medical GAAP EPS of -$0.08, revenue of $0.03M | 2 | Seeking Alpha | ||
| 11.05. | Envoy Medical, Inc.: Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant | 280 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - May 11, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions... ► Artikel lesen | |
| 11.05. | Envoy Medical, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Envoy Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.04. | Envoy Medical presents early data from cochlear implant trial | 3 | Investing.com | ||
| 28.04. | Envoy Medical, Inc.: Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant | 444 | Newsfile | Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Quality of Life Scores Presented; Additional Presentations Scheduled in Early MayDetails to be Discussed... ► Artikel lesen | |
| ENVOY MEDICAL Aktie jetzt für 0€ handeln | |||||
| 22.04. | Envoy Medical, Inc.: Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant | 265 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 21.04. | Envoy Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.04. | Envoy Medical, Inc.: Envoy Medical Appoints Chas McKhann to Board of Directors | 281 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today... ► Artikel lesen | |
| 13.04. | Envoy Medical, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 01.04. | Envoy Medical, Inc.: Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant | 296 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, announced... ► Artikel lesen | |
| 27.03. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.03. | Envoy Medical GAAP EPS of -$1.23, revenue of $0.02M | 1 | Seeking Alpha | ||
| 23.03. | Envoy Medical, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 23.03. | Envoy Medical, Inc.: Envoy Medical Reports Full Year 2025 Financial Results | 678 | Newsfile | Received FDA approval to expand fully implanted Acclaim Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end... ► Artikel lesen | |
| 11.03. | Envoy Medical, Inc.: Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant | 389 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - March 11, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 11.03. | EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear | 2 | Benzinga.com | ||
| 27.02. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 38,780 | -2,83 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.05.2026 /... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,500 | -0,03 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Siemens Healthineers von 42 auf 38 Euro gesenkt, aber die Einstufung auf "Hold" belassen. Für die Aktien dürfte eine überdurchschnittliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,260 | -3,89 % | Dividendenbekanntmachungen (22.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6712 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0645 EUR ADVANCED ENERGY INDUSTRIES... ► Artikel lesen | |
| QTREX QUANTUM | 0,715 | +136,08 % | Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity | RA'ANANA, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that, at the opening of trading on the Nasdaq... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,000 | +0,24 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,48 | +0,84 % | BMO raises BrightSpring Health stock price target on generic drug outlook | ||
| PROGYNY | 24,880 | +0,77 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| LIFESTANCE HEALTH GROUP | 7,390 | -0,94 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,330 | -0,24 % | Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity | ||
| PRIVIA HEALTH GROUP | 22,790 | +0,66 % | Privia Health Group, Inc. - 8-K, Current Report | ||
| GENEDX | 47,310 | -0,04 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| BILLIONTOONE | 85,92 | -0,27 % | Jim Cramer on BillionToOne: "I Say Buy It" | ||
| CO-DIAGNOSTICS | 5,075 | +36,79 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| BETA BIONICS | 11,820 | +11,40 % | Beta Bionics earmarks Q2 2027 for Mint patch pump launch, shares details on new tech | ||
| CARL ZEISS MEDITEC | 26,280 | +1,00 % | Carl Zeiss Meditec-Aktie: Sind das bereits gute Einstiegskurse? | Die Aktie des Medizintechnikunternehmens Carl Zeiss Meditec kommt weiterhin nicht zur Ruhe. Das schwache Marktumfeld und die zurückhaltende Investitionsbereitschaft vieler Kunden belasten das Geschäft... ► Artikel lesen |